Innovations driving biomarker evaluation and use.
Department of Clinical Pharmacology, Merck Research Laboratories, 126 East Lincoln Avenue, PO Box 2000, RY34-A548, Rahway, NJ 07065, USA. wagner@merck.com
John A
JA
Wagner
D058186:Acute Kidney Injury / Q000139:chemically induced / Q000175:diagnosis; D000818:Animals; D054316:Biomarkers, Pharmacological; D002317:Cardiovascular Agents / Q000494:pharmacology; D003663:Decision Trees; D055808:Drug Discovery / Q000379:methods* / Q000639:trends*; D023381:Endpoint Determination / Q000379:methods / Q000639:trends; D006801:Humans; D010372:Pediatrics; D057285:Precision Medicine / Q000639:trends; D040901:Proteomics / Q000379:methods / Q000639:trends; D011634:Public Health / Q000639:trends; D057170:Translational Research, Biomedical / Q000639:trends; D014481:United States; D014486:United States Food and Drug Administration
D054316:Biomarkers, Pharmacological; D002317:Cardiovascular Agents